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Inadequate tissue perfusion is a key contributor to early complications following reconstructive procedures.
Accurate and reliable intraoperative evaluation of tissue perfusion is critical to reduce complications and improve
clinical outcomes. Clinical judgment is the most commonly used method for evaluating blood supply, but when
used alone, is not always completely reliable. A variety of other methodologies have been evaluated, including
Doppler devices, tissue oximetry, and fluorescein, among others. However, none have achieved widespread
acceptance. Recently, intraoperative laser angiography using indocyanine green was introduced to reconstructive
surgery. This vascular imaging technology provides real-time assessment of tissue perfusion that correlates with
clinical outcomes and can be used to guide surgical decision making. Although this technology has been used for
decades in other areas, surgeons may not be aware of its utility for perfusion assessment in reconstructive surgery.
A group of experts with extensive experience with intraoperative laser angiography convened to identify key issues
in perfusion assessment, review available methodologies, and produce initial recommendations for the use of this
technology in reconstructive procedures.
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One of the fundamental causes of early complications
following reconstructive procedures is considered to be
inadequate tissue perfusion [1-6]. Therefore, accurate
and reliable intraoperative evaluation of tissue perfusion
is critical to reduce complications and improve clinical
outcomes. Clinical judgment is the most widely used
method for evaluating blood supply [7], but by itself is
not always completely reliable for assessment of flap per-
fusion [8,9]. Several technologies to assess tissue vascu-
larity have been evaluated in studies and used clinically,
but none have achieved universal acceptance [6,10].
Intraoperative laser angiography using indocyanine
green (ICG) is a vascular imaging methodology that can
be used in the intraoperative or postoperative setting to* Correspondence: michael.zenn@duke.edu
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reproduction in any medium, provided the orvisually assess superficial blood flow. Characteristics of
ICG angiography make it a desirable option for tissue
evaluation. The technique provides real-time assessment
of tissue perfusion that has been correlated with clinical
outcomes [1,5,6,11,12] and guides surgical decision mak-
ing, such as flap design or intraoperative tissue resection
[13]. ICG has an excellent safety profile and short
plasma half-life, allowing for repeat evaluations during
the same operative procedure. Although this technology
has been used for decades in ophthalmology, its intro-
duction to reconstructive surgery is relatively recent,
and surgeons may not be aware of its characteristics,
indications in reconstructive surgeries, and best practices
in the intraoperative setting.
In May of 2011, a group of 7 experts (6 plastic sur-
geons and 1 general surgery resident) with extensive ex-
perience in the use of SPY Intraoperative Perfusion
Assessment System (distributed in North America by
LifeCell Corp., Branchburg, NJ; manufactured by Novadaql Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Methods for evaluation of tissue perfusion, by setting
















→Does not identify precise
vessel location or course through




→Confirm perfusion of tissue
prior to incision, after elevation
of flaps, and prior to final closure
→Strong safety profile























et al., 2002 [21]
Holm, Mayr, et al.,
2002 [22]
Still et al. 1999
[23]
Doppler – handheld →Identification of
perforator vessel location
→Easy to use →Provides information on
discrete area below probe
Yu & Youssef,
2006 [29]
→Widely available →Requires direct skin contact




→Provides limited data and accuracy
for flap design,
→especially in heavier patients
→Difficult to quantify





→Single use only Phillips et al.,
2012 [12]
→Widely available →No venous information Losken et al.,
2008 [51]→Long delay time
→Toxicity concerns
→Use of ultraviolet Woods lamp
→High sensitivity, low specificity
Preoperative
Clinical judgment →Estimation of tissue
perfusion and flap viability
→Familiarity, ease of use →Poor reliability when used alone Phillips et al.,
2012 [12]
→Dependent on surgeon experience Mothes et al.,
2004 [8]
→Inferior to imaging modalities
for estimation of flap survival
Olivier et al.,
2003 [9]
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Table 1 Methods for evaluation of tissue perfusion, by setting (Continued)
Holm, Tegeler






→No exposure to ionizing
radiation or contrast media
→Inferior to CT angiography for
identification of vessel location
Rozen et al.,
2008 [24]
→Estimate of vessel flow rate →Provides estimation of
perforator location, caliber,
and flow
→Considered operator-dependent Khalid et al.,
2006 [25]












location and tissue perfusion
→No exposure to ionizing
radiation or contrast media
→May underestimate flap survival Schlosser et al.,
2010 [30]








CT angiography →Visualization of location and
course of vessels through muscles
and fascia
→Accurate detection of
anatomic location and course
of vessels




→Does not show perforator
perfusion zones








→Exposure to ionizing radiation Cina et al., 2010
[36]








MR angiography →Visualization of location and




→Does not assess vascular flow Schaverien et al.,
2011 [42]
→Detection of small caliber
vessels






→Less spatial resolution compared
to CT angiography
Greenspun
et al., 2010 [45]
→No exposure to ionizing →Potential toxicity of contrast Chernyak et al.,
2009 [41]
→radiation →media Neil-Dwyer















→Numeric output only Lin et al., 2011
[48]
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Table 1 Methods for evaluation of tissue perfusion, by setting (Continued)
→Improves flap salvage







* Includes evidence from use of ICG intraoperative perfusion assessment devices available outside the United States.
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convened a summit to develop a review describing the
current state of the art of evaluation of tissue perfusion in
reconstructive surgery. All of the authors use the SPY Sys-
tem, which has received FDA clearance for use in cardio-
vascular procedures; plastic, micro- and reconstructiveTable 2 Clinical evidence of utility the SPY system, by applica




Case series Multiple indications: head
















Case series Breast reconstruction:




Case series Breast reconstruction: tissu
expander, latissimus dorsi
flaps, DIEP/SIEA
N = 20 patients, 24 breasts
Tamburrino
et al., 2010 [17]
Retrospective analysis Breast reconstruction: tissu
expander or unilateral TRA
Tissue expander
(n = 11 patients,
19 breasts)
Unilateral TRAM (n = 1)
Francisco et al.,
2010 [52]
Case series N = 5 Breast reconstruction: DIEP
Jones et al.,
2009 [14]
Case series Breast reconstruction: free
pedicle TRAM, DIEP, latissim
and expander insertions.
N = 43 patients, 64 breasts
Newman &
Samson, 2009 [11]
Case series Breast reconstruction: DIEP




Case series Breast reduction surgery
N = 12 patients, 22 breasts
DIEP: deep inferior epigastric perforator.
NAC: nipple-areolar complex.
SIEA: superficial inferior epigastric artery flap.
TRAM: transverse abdominus musculocutaneous.surgical procedures; organ transplant; and gastrointestinal
surgical procedures. The goals of this summit were to
describe clinical uses for the SPY System in reconstructive
surgical procedures and to produce a set of technical
recommendations for its use. An extensive literature review




1 partial flap loss
ICG and fluorescein had sensitivity of 90% and specificity of
50% and 30%, respectively; negative predictive value for ICG
and fluorescein was 88% and 82%, respectively.
ICG perfusion assessment identified perfusion zones; no
issues with wound healing or tissue or fat necrosis.
e Tissue expander (n = 16), latissimus dorsi (n = 2), DIEP/SIEA
(n = 6); complication rate: 4% with ICG vs. 15.1% in 206
previous reconstructions (n = 148; p < 0.01)
e
M
95% correlation between ICG imaging and clinical
outcome, 100% sensitivity and 91% specificity.
No flap loss, fat necrosis, or take-backs
and
us dorsi,
Of 5 patients with poor flap perfusion on ICG imaging, 4
developed necrosis and 1 blistering in a pattern predicted
by ICG; necrosis rate of 6.3% vs. published rates of 15-25%.
or ICG detected marginal or poor perfusion in 4 cases; 3 were
revised intraoperatively and the 1 that was not revised
required return to OR for venous congestion. Flap survival
was 100%.
ICG used to demonstrate NAC perfusion and venous outflow
during surgery.
Table 3 Overall recommendations regarding use of the
SPY System in reconstructive procedures, by flap type
Application Points of use for ICG intraoperative laser angiography
Free flaps 1. Identify perforator perfusion zone in donor site prior to
incision; select optimal perforator and design flap
2. Confirm flap perfusion during dissection, testing and
comparing different perforators
3. Confirm flap perfusion after transfer
4. Confirm patency of arterial and venous anastomoses
5. Detect areas of venous congestion by re-imaging 5–
20 min after administration of ICG; can be performed
following flap dissection, transfer, and/or inset
Pedicle flap 1. Identify perforator perfusion zone in donor site prior to
incision; design flap
2. Evaluate arterial and venous perfusion after elevation
of flap and prior to transfer
3. After transfer and after inset, confirm arterial inflow and
venous return
Skin flap 1. Evaluate perfusion prior to incision; design flap
2. After dissection, confirm flap perfusion
3. After transfer and inset, confirm perfusion of flap
Mastectomy
flap
1. Following mastectomy, confirm integrity of vascular
perfusion in mastectomy flaps; select delayed vs.
immediate reconstruction; select implant vs. expander
reconstruction
2. Confirm perfusion after insertion of reconstructive
modality; determine expander volume or implant size;
determine skin paddle size
3. If revisions made, confirm perfusion in flaps
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Dissection of tissue of any kind is accompanied by some
degree of devascularization, and accurate determination
of tissue viability is critical to all surgeons. Loss of skin
flaps due to ischemia and postoperative necrosis can be
catastrophic and may result in an even larger tissue def-
icit requiring repair. Early identification of insufficiently
perfused tissue with the potential to develop ischemia or
postoperative necrosis will help guide intraoperative de-
cision making, such as the need for flap revision, tissue
resection, or a delayed procedure.
The wide variation in anatomic location of perforating
vessels and their perfusion zones makes vessel selection
and flap design a clinical challenge. Therefore, a reliable
method to identify perforating vessels and their perfusion
zones, assess tissue perfusion, and identify tissue at risk for
necrosis would be valuable to surgeons. Clinical judgment
alone remains the most commonly used intraoperative
method to determine the degree of tissue perfusion [7].
Although clinical judgment is an important tool and pro-
vides relevant information, studies have demonstrated thatclinical assessment alone can at times be a poor predictor
of postoperative complications [8,9,12].
The SPY System provides a clinically useful assessment
of perfusion in a variety of applications, including free
and pedicle flaps and mastectomy and other skin flaps
[14]. The technique allows for visualization of arterial in-
flow, venous return, and tissue perfusion during the
intraoperative period. The information provided by this
technique augments and strengthens clinical judgment
and provides the surgeon with real-time visualization of
tissue perfusion and vascular changes that result from
surgical maneuvers.
The SPY System utilizes a fluorescence agent, indocya-
nine green (ICG), to enable visualization, similar to
fluorescein in the past. Certain characteristics of ICG
make it a more beneficial tool for intraoperative perfu-
sion assessment. The ICG molecule binds strongly to
plasma proteins, causing it to remain in the intravascular
space. It also has a short plasma half-life of 3 to 5 minutes
in humans [15]. This pharmacokinetic profile allows for
rapid clearance of dye from tissues and repeated evalua-
tions during the same surgical procedure. In comparison,
the dye fluorescein stays in the tissue for more than
12 hours, meaning that it can be used only once. ICG is
administered by means of peripheral or central intraven-
ous access, is excreted exclusively by the liver into the bile,
and is not associated with risk for nephrotoxicity. The
laser diode array utilized by the SPY System emits a near-
infrared wavelength that does not require the use of
protective eyewear or other safety equipment.
The SPY System is currently indicated for capturing and
viewing fluorescence images for the visual assessment of
blood flow as an adjunctive method for the evaluation of
tissue perfusion and related tissue-transfer circulation in
tissue and free flaps used in plastic, micro-, and recon-
structive and gastrointestinal surgical procedures. The sys-
tem is used in evaluating recipient site vascularity as well
as circulation in tissue flaps and free flaps used in plastic,
microsurgical, and reconstructive surgical procedures
[15]. For plastic and reconstructive surgery applications,
the SPY System can be used to evaluate perfusion in all
components of the flap, including skin, fat, fascia, muscle,
periosteum, nipple (in breast reconstruction, reduction,
and mastopexy), and arterial and venous flow in vessels
(in microsurgery).
The recommendations and the authors’ personal experi-
ences pertain to the SPY Intraoperative Perfusion Assess-
ment System. This system utilizes a laser diode array to
illuminate a maximum field of 18.5 × 13.5 cm2 [15]. A
charge-coupled device camera can be configured to capture
image sequences at 3.75 to 30 frames per second, depen-
ding on the desired recording time of between 30 seconds
and up to a maximum of 4.5 minutes. Images are viewed
on a high-definition monitor in real time, allowing for
Table 4 Technical recommendations for use of the SPY System
Application Timing of evaluation*
Microvascular reconstructive surgery
Pre-incision identification of perforators 15-30 sec
Following dissection, confirmation of adequate flow and limits of perfusion 1-2 min
Following transfer, evaluation of arterial and venous anastomoses Arterial phase: instantaneous.
Venous phase: 30–60 sec
Re-image at 2 min; if venous congestion is
suspected, evaluate again at ≥4 min
Following inset, confirmation of adequate flow and limits of perfusion 1-2 min (Wait at least 10 min following previous
ICG administration)
Pedicle flap reconstruction
Pre-incision identification of perforator perfusion zone ≤1 min
Following elevation of flap, confirmation of adequate flow and limits of perfusion
(selection of skin and soft tissue for preservation)
1-2 min
Following transposition and inset, confirmation of adequate flow and limits of perfusion 1-2 min
Skin flap reconstruction**
Following elevation of skin flap, define limits of perfusion for flap design and detect
sub-clinical ischemia
1-2 min
Following transposition and inset to confirm adequate perfusion 1-2 min (Wait at least 10 min following previous
ICG administration)
Mastectomy followed by TE/I reconstruction
Pre-mastectomy, map the vessels and the perfusion surrounding the nipple-areolar complex 15-30 sec
Following mastectomy, assess perfusion along the skin/tissue edges of the flap† Wait
30–45 minutes following completion of mastectomy procedure to ensure recovery of
perfusion. If no fluorescence is detected after this time period, additional wait time of
up to 30 minutes may be appropriate.
3-4 min
With implant or tissue expander in place, evaluate mastectomy skin flap prior to filling expander Wait 5 min after insertion of implant or tissue
expander before imaging
After filling tissue expander, evaluate skin flaps, nipple-areolar complex, and surrounding
tissue perfusion
Wait 5 min after filling tissue expander before
imaging
TE/I = tissue expander/implant.
* Start recording after first appearance of fluorescent blush. Times given indicate when within the captured image sequence assessments should be made.
**For areas or conditions associated with reduced perfusion (eg, lower extremities, vasculopathy), longer wait times may be required before evaluation.
Notes: The Instructions for Use supplied with SPY note that the 25 mg ICG should be reconstituted in 10 cc of normal saline, giving a concentration of 2.5 mg/cc
[15]. The Instructions for Use suggest administration of 10 mg (or 4 cc) ICG for visualization of tissue perfusion. For restudy, wait ≥10 min from previous injection
of ICG. Take a baseline image before restudy to ensure that ICG has washed out. If complete wash out is needed, wait 15 minutes from previous ICG
administration.
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puter hardware and software for capturing, enhancing
visualization, and archiving of images and creation and
printing of imaging procedure reports [11]. A companion
post-processing software product (SPY-Q™ Analysis
Toolkit) provides additional viewing, comparison, and
analysis tools, including algorithms for measurement
of fluorescence intensity. The clinician retains ultimate
responsibility for making the pertinent diagnosis based on
their standard clinical practices and visual comparison of
the images.
Modalities for assessment of tissue perfusion
Clinical judgment for flap evaluation involves subjective
indices, such as tissue color, capillary refill, flap
temperature, and dermal bleeding. When used alone,
even by experienced surgeons, clinical judgment mayinaccurately assess adequacy of tissue perfusion and predict
ultimate outcomes.
Surgeons have evaluated and incorporated adjunctive
modalities for assessment of vascular anatomy and, in
some cases, tissue perfusion. Multiple modalities have
been used clinically and described in the literature, in-
cluding various Doppler devices, computed tomography
angiography (CTA), magnetic resonance angiography
(MRA), tissue oximetry, and fluorescein, among others
(Table 1) [1,8,9,11,12,14,16-52].
Intraoperative use of hand-held Doppler is safe, simple,
and widely available. Several authors have described the
preoperative use of Doppler ultrasound to identify vessel
location [27,28]. However, the technique is considered an
operator-dependent procedure [27], does not identify the
perforator perfusion zone, and provides limited informa-
tion and accuracy for flap design [29]. Evidence suggests
Table 5 Examples of flap types and procedures










Skin flap over pectoralis major
Degloving injuries, upper and lower extremity
Abdominal flaps (eg, hernia repair)
Component separation
Burn injuries




Pedicle flaps TRAM flap







Lateral intercostal artery flap











Breast reconstruction Implant reconstructions
Tissue expander reconstructions
ALT: anterolateral thigh flaps.
DIEP: deep inferior epigastric perforator.
SIEA: superficial inferior epigastric artery.
TRAM: transverse abdominus musculocutaneous.
VRAM: vertical rectus abdominus myocutaneous.
DCIA: deep circumflex iliac artery.
TUG/TMG: transverse (myocutaneous) gracilis.
GAP: gluteal artery perforator.
PAP: profunda artery perforator.
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vessel caliber.
It has been suggested that laser-Doppler flowmetry
can be used for evaluation of blood flow within flaps.
However, when used intraoperatively, it may underesti-
mate flap survival [33]. The technique is also sensitive to
small movements and is cumbersome. A recent study
reported that although laser Doppler was effective at
identifying ischemia in free flaps, it had poor ability to
detect perforator vessels [30].
CTA and MRA are often used for preoperative
evaluation of perforator vessel location. These meth-
ods provide accurate visualization of the anatomic
course of vessels through the muscle and fascia
[24,34-46]. However, neither provides information
regarding blood flow through these vessels, nor the
extent of perfusion from the perforator. Information
provided by CTA/MRA and intraoperative laser angi-
ography with ICG can be considered complementary;
CTA and MRA accurately identify vessel location,
whereas ICG provides information regarding the real-
time location and extent of perfusion at the level of
the skin.
Transcutaneous oxygen monitoring has been shown
to improve flap salvage rates when used for post-
operative monitoring [47,48]. Some investigators have
brought this technique into the intraoperative setting,
but it can be time consuming and labor intensive for
mapping flaps. Initial findings suggest that it may
have utility for continuous monitoring of flap perfu-
sion [49,50].
Fluorescein angiography has been used to evaluate tis-
sue perfusion in the operating room. The limitations of
fluorescein include a long half-life, rapid leakage from
capillaries into the interstitium, and a clearance time of
12 to 18 hours, which precludes re-evaluation during
the intraoperative period [22,53-55]. Local ischemia
enhances fluorescein diffusion, potentially leading to
false-positive results [53,56]. Recent data suggest that
fluorescein is not as accurate as intraoperative laser
angiography, with lower specificity and negative predic-
tive value [12,21,22,51]. Toxicity of the contrast medium
is also a concern.Evidence of utility for intraoperative Use of the
SPY system
ICG has been successfully used to evaluate perfusion in
ophthalmologic procedures for decades [57,58]. More
recently, the technology was adopted for use in cardiac
[59,60], vascular [61,62], and transplant surgery [63].
Over the last decade, surgeons have applied the technology
to plastic reconstructive surgical procedures, demonstrating
clinical utility [1,11,12,16,22,52].
Figure 1 Illustration of the use of SPY to assist in the design of transverse abdominus musculocutaneous (TRAM) flap for breast
reconstruction in two patient cases. Panel A shows a schematic illustration of the best perfused tissue in the TRAM flap for Case 1. This flap was
designed based on the corresponding SPY image (Panel C), which demonstrated good perfusion in zone 1, clearly definable and in contrast to the
poor perfusion across the midline in zone 3. In contrast, Panel B shows the schematic flap design for the TRAM flap in Case 2 based on the SPY image
(Panel D), which demonstrated good perfusion in zone 1 and to a clearly definable point in zone 3 (dotted line). Lateral to this point in zone 3,
fluorescence on SPY remained poor, indicating areas of relative ischemia and potential tissue loss. This information was originally published in Can J
Plast Surg 2011;19(1):e1-e5.
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reconstructive surgeries
Clinical experience with intraoperative laser angiography
for visualization of tissue perfusion during reconstruc-
tive surgical procedures is summarized in Table 2. Studies
in reconstructive surgical procedures have reported good
correlation between ICG-visualized circulation and pos-
toperative outcomes [13,23,64-66]. In case series and
prospective studies, adequate intraoperative perfusion
assessment using SPY was associated with reduced
rates of postoperative necrosis and flap loss compared
to clinical judgment alone in a variety of reconstruc-
tive procedures, including free flap, pedicle flap, and
implant reconstructions [1,5,8,11,14,18,20-22,67].
Recommendations for the intraoperative Use of SPY
Using clinical experience and published evidence, the
authors developed recommendations for the intraopera-
tive use of the SPY System to assess tissue perfusion inreconstructive surgical procedures. These recommen-
dations are not intended to be prescriptive, but ra-
ther, to serve as general principles for the use of the
SPY System in the intraoperative evaluation of tissues
during reconstructive surgical procedures. The overall
principles agreed on by the authors are listed by in-
dication in Table 3. Specific technical recommenda-
tions regarding the use of the SPY System are also
provided, including dosing of ICG and timing of
evaluation (Table 4). A partial list of the types of
flaps that may be appropriate for evaluation with
SPY is provided in Table 5. The authors’ use of SPY
in various reconstructive applications is illustrated in
Figures 1, 2, 3 and 4.
Free flaps
The sequence of steps at which perfusion assessment
with ICG for free flaps should be considered is illu-
strated in Table 3. The surgeon may consider performing
Figure 2 In this case, a 45-year-old woman with right breast cancer (Panel A) requested expander insertion to maintain domain during
chemotherapy and radiation therapy prior to autologous conversion. SPY image (Panel B) identified poor perfusion in an extensive
area around the incision. Clinically, the skin appeared well perfused and was preserved based on clinical judgment. Postoperative
ischemia ensued, leading to full-thickness necrosis (Panel C). Two attempts at salvage with debridement and expander deflation failed
to achieve successful closure, and the expander was removed to allow the patient to proceed with chemotherapy and radiation
therapy. The resulting healed, radiated mastectomy site prior to free TRAM reconstruction is shown in Panel D.
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site to aid in flap design, during harvest of the flap to aid
in vessel selection, and after flap elevation to aid in de-
termining which parts of the flap should be used and
where they should be positioned.
The pattern of ICG fluorescence can also be used
to evaluate venous return. With SPY, venous conges-
tion manifests as an area of brightness that persists
for 5 to 20 minutes after administration of ICG. Per-
sistent fluorescence often appears “hyper-white” on
the monitor, suggesting that plasma-bound ICG is
trapped within the perfusion zone. Re-imaging the
flap 5 to 20 minutes after ICG injection can identify
venous congestion following dissection, transfer, and/
or inset. Persistent fluorescence in a free flap suggests
the presence of venous thrombosis, a kinked vein, or
improperly designed flap. With repeated injections of
ICG (i.e., ≥4 injections), there may be some residual
background fluorescence that must be distinguished
from venous congestion.Pedicle flaps
For pedicle flaps, the SPY System can be used to identify
perforator perfusion zones and optimize design of the skin
paddle over the perfusion zone (see Table 3). Once the flap
has been designed and elevated, ICG may be administered
to confirm viability of the flap prior to transfer and again
following inset. After each of these steps, the ICG fluor-
escence pattern can help to identify problems, such
as compressed or kinked vessels in the pedicle, as
well as areas of poor perfusion that may require de-
bridement or adjustments to flap inset, such as delay
of inset, minimizing postoperative tissue necrosis.Mastectomy flaps
Following completion of a mastectomy procedure, the
SPY System can help to determine the viability of mas-
tectomy flaps (see Table 3). This information can be
used to maximize use of the mastectomy skin, thereby
improving aesthetics by minimizing the need for larger
Figure 3 Latissimus dorsi (LAT) flap evaluated using SPY. Necrosis of the tips of transversely oriented LAT flaps can occur in some
patients; the use of SPY identifies these regions intraoperatively. Panel A shows a SPY image of a LAT flap (head to the left, legs to
the right) following rotation to the chest for breast reconstruction. The image shows two parallel scars from a previous biopsy with
evidence of poor blood supply across the scars. This area was resected (arrow). Similarly, Panel C shows poor perfusion in the tip of
the LAT flap and its underlying muscle (bracket). It is assumed that these regions of LAT flaps in some patients are outside the
primary angiosome of the thoracodorsal artery and are supplied by smaller vessels that are divided in the normal harvest of the flap.
In both cases, the tissues look perfectly normal clinically (Panel B, arrow and bracket). Each of these regions should be debrided prior
to use in reconstruction. As illustrated by this case, variable anatomy can lead to areas of poor perfusion, despite good flap design
and excellent surgical technique, that can only be identified through intraoperative imaging.
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burden.
Implant reconstruction
The SPY System can provide information about the
effects of tension and pressure on perfusion in the
mastectomy flap, which may help to inform decisionsFigure 4 Illustration of the use of SPY to optimize placement of skin
reconstructive surgery. The proposed center of the ALT flap, in the right
between the anterior superior iliac spine (A) and the lateral patella (P) in p
Panel B, identifies perforator perfusion zones in red along the AP line axis.
showing the locations of perforator perfusion zones. Partial elevation of the
vastus lateralis muscle and rectus femoris muscle, corresponding to the pe
often show significant variation in perforator location, exposing the weaknregarding immediate implant placement or expander in-
flation volume. When tissue expanders are used, the effect
of expander volume on skin flap perfusion can be moni-
tored in real time, and decisions can be made regarding
appropriate intraoperative fill volumes [1,13,68]. A final
image may be obtained to confirm adequate flap perfusion
following modification to the expander, implant, or skin.paddle for harvest of the anterolateral thigh (ALT) flap for
thigh, is marked in standard fashion at the midpoint of a line drawn
reparation for harvest (Panel A). The colorized SPY Q analysis, shown in
The color SPY image is transposed over the native thigh in Panel C,
ALT flap (Panel D) shows perforators (circled) emanating from the
rforator perfusion zones identified by SPY in Panels B and C. SPY will
ess of standard flap design.
Table 6 Variables that may impact use of modalities to
evaluate tissue perfusion
Characteristics associated with ischemia Previous radiation treatment











Agents that affect blood flow Vasoconstrictors
(eg, epinephrine)**
*Previous incisions may affect blood flow; ICG perfusion assessment may be of
particular utility for detection of perfusion across scars.
**Vasopressors affect all methods of estimation of perfusion in tissue.
Diminished blood flow following administration of epinephrine may indicate
the need to wait ≥2 hours for accurate ICG imaging. A negative result on ICG
perfusion assessment may indicate the need to wait longer for recovery of
perfusion.
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The SPY System can be used to evaluate perfusion of
the mastectomy skin and the nipple-areolar complex
(NAC) during a skin-sparing, nipple-sparing mastec-
tomy. After completion of mastectomy, the NAC can be
evaluated by examining both its superficial and deep
surfaces to help determine whether the NAC should be
retained. By examining the NAC with a sizer in place, the
SPY System can aid in the decision to go straight to
implant or to perform a staged reconstruction, minimizing
risk of necrosis in the areas at risk.
Other skin flaps
Intraoperative laser angiography can be utilized to evalu-
ate perfusion in multiple types of skin flaps (see Table 5
for examples). Imaging can be performed prior to inci-
sion to evaluate perfusion in the donor site and design
the flap, during flap elevation to select the number and
location of perforating vessels, following dissection to
confirm viability of the flap, and again after transfer and
after inset to confirm perfusion and rule out compression
or kinking that may have occurred after flap transfer.
Improved perfusion assessment can also assist in the deci-
sion to delay reconstruction, if perfusion is determined to
be inadequate.
Benefits in challenging morphologies
In the authors’ experience, intraoperative laser angiog-
raphy has particular clinical utility in cases where clinical
judgment may be challenging, such as patients with dar-
ker skin tones and/or severe bruising or other tissue
damage. Pigmentation or discoloration of the skin inter-
fere with clinical assessment but are transparent to the
SPY system. Perfusion across scars can also be visualized
using SPY technology, whereas clinical assessment may
be of limited utility.
Amount and timing of ICG administration and coordination
with image capture
The recommendations include specific guidance regarding
the method and timing of ICG administration, the timing
of image capture with the SPY System, and the use of re-
peat evaluations during the same procedure (see Table 4).
ICG is administered via intravenous bolus, using the best
available venous access (central or peripheral), followed by
a 10 cc bolus of normal saline.
Positioning the SPY device, injecting the ICG, and cap-
turing the images requires coordination between surgeon
and anesthesiologist to ensure that useful images are
acquired. Surgeons should ensure that the SPY camera is
on and recording before the first blush of fluorescence is
seen. Newer versions of the SPY System include a 5-second
buffer whenever the camera is on; therefore, images will be
captured from 5 seconds prior to initiation of recording.The maximum capture time is 4.5 minutes, but additional
scans may be performed immediately after this period,
extending the study without additional injection of
ICG [15].
Special considerations
Factors that may affect the use of the SPY System are
listed in Table 6. Characteristics associated with ischemia
(eg, smoking and peripheral vascular disease) may lead
to reduced fluorescence and longer wait times following
administration of ICG. Dyes, such as methylene blue,
can interfere with the fluorescent image. Vasoconstrictors,
such as epinephrine, drastically diminish blood flow and
preclude accurate estimation of normal tissue perfusion.
The SPY-Q Analysis Toolkit companion software allows
for quantification of perfusion by assigning numeric values
to intensity of fluorescence. Two types of values can be
used: relative and absolute. Relative values are normalized
to a reference value based on an image taken from tissue
outside the area of interest, but within the field of view.
Absolute values pertain strictly to the intensity of fluores-
cence signal in any given image. In the opinion of the
authors, and based on the currently available technology,
absolute values may have greater utility for quantification
of perfusion than relative values, which depend on an
arbitrary reference image from an area of normal perfu-
sion. The utility of these values for prediction of necrosis
remains to be determined. An analysis of images from a
study of breast reconstruction using this software [12]
suggested that quantification using absolute values may be
useful to stratify tissue perfusion into three categories:
viable tissue, tissue at high risk for necrosis, and tissue
that should be evaluated in correlation to other clinical
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these values in prediction of postoperative complications.
Other factors that should be considered when using the
SPY System include turning off ambient lighting to improve
fluorescent image viewing (and on for visible photography),
positioning the camera head perpendicular to the body sur-
face being imaged, ensuring the patient is normothermic
and normotensive, and administering ICG through the
largest available intravenous access.
Safety of ICG
ICG has an excellent safety profile, with an adverse
event rate of approximately 1 in 42,000 patients [69,70].
Anaphylactic reactions are rare, but can occur in patients
with iodine sensitivity. The recommended maximum dose
of ICG is 2 mg/kg [15].
Summary
The elevation of tissue of any type results in potential
devascularization and the risk for vascular compromise.
The use of simple, reliable, and accurate adjunctive mo-
dalities to assist the surgeon in determining vascular
compromise or poor perfusion will provide surgeons the
opportunity to intervene early and minimize risk for
postoperative complications.
The SPY Intraoperative Perfusion Assessment System
has clinical utility for the perioperative visualization of tis-
sue perfusion in multiple settings. The authors propose
recommendations regarding the applications and most
effective use of this technology for a range of plastic and
reconstructive procedures. As this technology is more
widely adopted and studied in the reconstructive setting,
refinements to these technique recommendations may
be made.
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